Arabic Arabic English English French French German German

Mayo finds convalescent plasma safe for diverse patients with COVID-19

ROCHESTER, Minn. – Mayo Clinic researchers and collaborators have found investigational convalescent plasma to be safe following transfusion in a diverse group of 20,000 patients. The findings — from the U.S. Food and Drug Administration’s Expanded Access Program for COVID-19 — are reported in Mayo Clinic Proceedings. The safety report assessed the seven days following […] Disclaimer: This story is auto-aggregated by a computer program and has not been created or edited by HFACULTY News. Publisher: News from Mayo Clinic Click this link to read the full content from the Publisher Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

UAE ranks first in terms of screening per capita; Government announces travel protocols for citizens, and residents

Next Post

Using knowledge mining to fast-track innovative treatments for disease

Related Posts